Equities

Shanghai Aohua Photoelectricity Endoscope Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Aohua Photoelectricity Endoscope Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)42.27
  • Today's Change-0.270 / -0.63%
  • Shares traded1.22m
  • 1 Year change+0.52%
  • Beta0.5477
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shanghai Aohua Photoelectricity Endoscope Co Ltd had net income fall -63.68% from 57.85m to 21.01m despite a 10.54% increase in revenues from 678.08m to 749.55m. An increase in the cost of goods sold as a percentage of sales from 27.17% to 32.96% was a component in the falling net income despite rising revenues.
Gross margin61.79%
Net profit margin-10.80%
Operating margin-16.04%
Return on assets-4.14%
Return on equity-5.51%
Return on investment-5.15%
More ▼

Cash flow in CNYView more

In 2024, Shanghai Aohua Photoelectricity Endoscope Co Ltd did not generate a significant amount of cash. Cash Flow from Financing totalled 53.35m or 7.12% of revenues. In addition the company used 78.93m for operations while cash from investing totalled 31.55m.
Cash flow per share--
Price/Cash flow per share--
Book value per share9.25
Tangible book value per share8.36
More ▼

Balance sheet in CNYView more

Shanghai Aohua Photoelectricity Endoscope Co Ltd has a Debt to Total Capital ratio of 20.86%, a higher figure than the previous year's 0.93%.
Current ratio2.13
Quick ratio1.57
Total debt/total equity0.2666
Total debt/total capital0.2086
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -73.33% and -62.79%, respectively. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-16.61
EPS (TTM) vs
TTM 1 year ago
-236.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.